Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility.
Aged
Antacids
/ therapeutic use
Deglutition Disorders
/ etiology
Esophageal Sphincter, Lower
/ physiopathology
Female
Follow-Up Studies
Fundoplication
/ methods
Gastroesophageal Reflux
/ complications
Hernia, Hiatal
/ complications
Humans
Laparoscopy
/ methods
Male
Manometry
Middle Aged
Peristalsis
Proton Pump Inhibitors
/ therapeutic use
Recurrence
Treatment Outcome
Anti-reflux surgery
Esophageal dysmotility
GERD
Laparoscopic partial fundoplication
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
21
06
2018
accepted:
09
09
2018
pubmed:
6
10
2018
medline:
27
2
2020
entrez:
6
10
2018
Statut:
ppublish
Résumé
Gastroesophageal reflux disease (GERD) and esophageal dysmotility are often disqualifying criteria for fundoplication due to dysphagia complications. A tailored partial fundoplication may improve GERD in patients with severe esophageal motility disorders. We evaluate this approach on GERD improvement in non-achalasia esophageal dysmotility patients. A single-institution prospective database was reviewed (2007-2016), with inclusion criteria of GERD, previous diagnosis of non-achalasia esophageal motility disorder, and laparoscopic partial fundoplication. Diagnosis of previous achalasia diagnosis or diffused esophageal spasm was excluded. Motility studies, pre- and post-upper gastrointestinal imaging (UGI), esophageal symptom scores, antacid, and PPI use were collected pre-op, 6 months, 12 months, and long-term (LT). Statistical analysis was made using SPSS v.23.0.0, α = 0.05. Fifty-two patients met the inclusion criteria. A total of 17.3% had esophageal body amotility, 79.6% had severe esophageal dysmotility. A total of 65.9% women (mean age 64 ± 15.7), mean peristalsis 45.3 ± 32.6%, and failed peristalsis 36.0 ± 32.2%. Mean LES residual pressure was 15.0 ± 18.0 mmHg, and 40.7% had hypotensive LES. Mean follow-up time was 25 months [1-7 years], with significant improvement in symptoms and reduction in PPI and antacid use at all time-points compared to pre-op. A total of 74% had UGI studies at 12 months; all showed persistent dysmotility. Six patients had radiographic hiatal hernia recurrence, with only one being clinically symptomatic postoperatively. Three required dilation for persistent dysphagia. A tailored partial fundoplication may be effective in symptom relief for non-achalasia patients with esophageal motility disorders and GERD. Significant symptom improvement, low HHR, and PPI use clearly indicate this approach to be effective for this population.
Sections du résumé
BACKGROUND
Gastroesophageal reflux disease (GERD) and esophageal dysmotility are often disqualifying criteria for fundoplication due to dysphagia complications. A tailored partial fundoplication may improve GERD in patients with severe esophageal motility disorders. We evaluate this approach on GERD improvement in non-achalasia esophageal dysmotility patients.
METHODS
A single-institution prospective database was reviewed (2007-2016), with inclusion criteria of GERD, previous diagnosis of non-achalasia esophageal motility disorder, and laparoscopic partial fundoplication. Diagnosis of previous achalasia diagnosis or diffused esophageal spasm was excluded. Motility studies, pre- and post-upper gastrointestinal imaging (UGI), esophageal symptom scores, antacid, and PPI use were collected pre-op, 6 months, 12 months, and long-term (LT). Statistical analysis was made using SPSS v.23.0.0, α = 0.05.
RESULTS
Fifty-two patients met the inclusion criteria. A total of 17.3% had esophageal body amotility, 79.6% had severe esophageal dysmotility. A total of 65.9% women (mean age 64 ± 15.7), mean peristalsis 45.3 ± 32.6%, and failed peristalsis 36.0 ± 32.2%. Mean LES residual pressure was 15.0 ± 18.0 mmHg, and 40.7% had hypotensive LES. Mean follow-up time was 25 months [1-7 years], with significant improvement in symptoms and reduction in PPI and antacid use at all time-points compared to pre-op. A total of 74% had UGI studies at 12 months; all showed persistent dysmotility. Six patients had radiographic hiatal hernia recurrence, with only one being clinically symptomatic postoperatively. Three required dilation for persistent dysphagia.
CONCLUSIONS
A tailored partial fundoplication may be effective in symptom relief for non-achalasia patients with esophageal motility disorders and GERD. Significant symptom improvement, low HHR, and PPI use clearly indicate this approach to be effective for this population.
Identifiants
pubmed: 30288691
doi: 10.1007/s11605-018-3968-6
pii: 10.1007/s11605-018-3968-6
doi:
Substances chimiques
Antacids
0
Proton Pump Inhibitors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
36-42Références
Surg Endosc. 2008 Jan;22(1):21-30
pubmed: 18027055
J Gastrointest Surg. 2002 Jan-Feb;6(1):22-7; discussion 27-8
pubmed: 11986014
Surg Clin North Am. 2015 Jun;95(3):467-82
pubmed: 25965124
J Gastrointest Surg. 2017 Sep;21(9):1544-1552
pubmed: 28623447
Ann Surg. 2017 Jul;266(1):23-28
pubmed: 28294958
Gastroenterology. 2018 Jan;154(2):267-276
pubmed: 28780072
J Gastrointest Surg. 1999 Nov-Dec;3(6):583-91
pubmed: 10554364
Surg Endosc. 2007 Feb;21(2):285-8
pubmed: 17122978
Gastroenterology. 2001 Jul;121(1):5-14
pubmed: 11438489
J Gastrointest Surg. 1997 Jul-Aug;1(4):301-8; discussion 308
pubmed: 9834362
J Gastrointest Surg. 2014 Oct;18(10):1723-9
pubmed: 25091845
Am Surg. 2018 Apr 1;84(4):481-488
pubmed: 29712593
Gut. 1997 Mar;40(3):381-5
pubmed: 9135529
Br J Surg. 1998 Sep;85(9):1290-3
pubmed: 9752880
Surg Endosc. 2002 Jun;16(6):909-13
pubmed: 12163953
Gut. 1995 Sep;37(3):305-8
pubmed: 7590421
Surg Endosc. 2018 Apr;32(4):1668-1674
pubmed: 29046957
BMC Gastroenterol. 2016 Aug 02;16(1):88
pubmed: 27484006
Surg Laparosc Endosc Percutan Tech. 2017 Feb;27(1):24-29
pubmed: 28145965
Surg Endosc. 2018 Sep;32(9):3855-3860
pubmed: 29435755
Br J Surg. 2017 Jun;104(7):843-851
pubmed: 28295217
Dig Surg. 2011;28(1):80-6
pubmed: 21293136
Einstein (Sao Paulo). 2016 Jul-Sep;14(3):439-442
pubmed: 26958977
Surg Obes Relat Dis. 2017 Apr;13(4):547-552
pubmed: 27889485
Surgery. 2017 Apr;161(4):977-983
pubmed: 28011013
J Gastrointest Surg. 2014 Jan;18(1):157-62; discussion 162-3
pubmed: 24234243
Dig Surg. 2014;31(4-5):354-8
pubmed: 25503359